Despite concerns that Medicare Advantage payment reductions included in the Affordable Care Act would lead to a decline in enrollment, the number and share of beneficiaries enrolling in Medicare Advantage has only continue to climb since the health reform law was enacted.
Medicare Advantage (MA) payment reductions that were included in the Affordable Care Act were controversial, with some concerned that the cuts would lead to a decline in enrollment in MA; however, since the enactment of the health reform law, the number and share of Medicare beneficiaries enrolling in MA has only continued to climb, according to a report from the Kaiser Family Foundation.
Since 2010, enrollment in MA has increased by 50%, and from 2014 to 2015 enrollment grew by more than 1 million beneficiaries, or 7%. There are now a total of 16.8 million beneficiaries, or 31% of the overall Medicare population, enrolled in MA plans.
“From the perspective of the Medicare program overall, it is clear that Medicare Advantage has become an increasingly important way in which Medicare beneficiaries receive their benefits and all signs suggest that this will only increase in the future,” the authors of the report wrote.
South Dakota and North Dakota saw particularly large increases in enrollment (19% and 18%, respectively). However, MA penetration in these states is relatively low. For example, the average state penetration rate is 31%, with Minnesota have the highest rate at 53%, followed by Hawaii (46%) and Oregon (44%). In comparison, Alaska has the lowest penetration rate with less than 1% of Medicare enrollees are in MA plans, followed by Wyoming (2%).
“While Medicare Advantage premiums have remained relatively flat, out-of-pocket limits have been increasing over the past few years, providing less financial protection to Medicare enrollees with significant medical needs than they have in the past,” the authors wrote in the report.
Monthly premiums for MA prescription drug plans increased $3 per month to $38 (7% increase), but premiums do vary across plan types and states. The share of enrollees in MA prescription drug plans with $0 premiums declined from 56% to 48%. Premiums also vary greatly by state. While the national average is $38, average monthly premiums are highest in Massachusetts ($107), Michigan ($93), Minnesota ($130), and Pennsylvania ($94) and lowest in Florida ($6), Nevada ($13), Arizona ($15), Louisiana ($15), and Iowa ($15).
The average out-of-pocket spending limits has risen to $5041. All plans are required to limit these expenses to no more than $6700.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More